← Back to Search

Procedure

Effect of Nasal Positive Airway Pressure Versus Standard Care on Oxygenation and Ventilation During Propofol-based Sedation for Colonoscopy in Patients With High Risk of Airway Obstruction

N/A
Waitlist Available
Led By Erikka Washington, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of procedure
Awards & highlights
No Placebo-Only Group

Summary

This trial compares a special nasal device that helps keep airways open to regular oxygen masks in obese patients or those with sleep apnea during colonoscopy. The goal is to see which method better supports breathing.

Eligible Conditions
  • Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~prior to endoscopic intubation,during the procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and prior to endoscopic intubation,during the procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Anesthesiologist satisfaction score as assessed by the visual analog scale (VAS)
Change in alertness of subject as assessed by the Modified Observer's Assessment of Alertness/Sedation Scale (MOAAS)
Patient satisfaction as assessed by the visual analog scale (VAS)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group B: SuperNO2VA™EtCO2Experimental Treatment1 Intervention
Group II: Group A: Standard care with a facemask.Active Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SuperNO2VA™EtCO2 (Nasal Oxygenating Ventilating Apparatus)
2022
N/A
~140

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
957 Previous Clinical Trials
347,718 Total Patients Enrolled
Vyaire MedicalIndustry Sponsor
10 Previous Clinical Trials
1,685 Total Patients Enrolled
Erikka Washington, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Media Library

Nasal Positive Airway Pressure (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05524220 — N/A
Sleep Apnea Research Study Groups: Group A: Standard care with a facemask., Group B: SuperNO2VA™EtCO2
Sleep Apnea Clinical Trial 2023: Nasal Positive Airway Pressure Highlights & Side Effects. Trial Name: NCT05524220 — N/A
Nasal Positive Airway Pressure (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05524220 — N/A
~46 spots leftby Dec 2025